Viable CD34+/CD133+ blood progenitor cell dose as a predictor of haematopoietic engraftment in multiple myeloma patients undergoing autologous peripheral blood stem cell transplantation

Overview of attention for article published in Annals of Hematology, May 2007

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (70th percentile)

Mentioned by

blogs: 1 blog

Citations

dimensions_citation: 16 Dimensions

Readers on

mendeley: 24 Mendeley

Summary Blogs Dimensions citations

So far, Altmetric has seen 2 posts from 1 blogs.

Optimizing the quality of cell therapy starting materials

RegMedNet, 01 Oct 2018

This article will elucidate the growing need for validated high quality cell therapy starting material and examine the impact…

Optimizing the quality of cell therapy starting materials

RegMedNet, 26 Sep 2018

This article will elucidate the growing need for validated high quality cell therapy starting material and examine the impact…